Differential indirect activation of human invariant natural killer T cells by toll-like receptor agonists

Immunotherapy

Volumn 1, Issue 4, 2009, Pages 557-570

  Moreno, María ^a,b   Mol, Berber M ^a   Von Mensdorff Pouilly, Silvia ^a   Verheijen, René H M ^a,c   De Jong, Ester C ^d   Von Blomberg, B Mary E ^a   Van Den Eertwegh, Alfons J M ^a   Scheper, Rik J ^a   Bontkes, Hetty J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute of Hygience   (Uruguay)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cell activation; Human; Invariant natural killer T cell; Monocyte derived dendritic cell; Toll like receptor

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; FLAGELLIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; OLIGODEOXYNUCLEOTIDE A; OLIGODEOXYNUCLEOTIDE DERIVATIVE; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN CLO75; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG MECHANISM; DRUG POTENTIATION; HUMAN; HUMAN CELL; MONOCYTE; NATURAL KILLER T CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL COMMUNICATION; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; FLAGELLIN; HUMANS; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; NATURAL KILLER T-CELLS; OLIGODEOXYRIBONUCLEOTIDES; PEPTIDOGLYCAN; POLY I-C; QUINOLINES; THIAZOLES; TOLL-LIKE RECEPTORS;

EID: 77953450389     PISSN: 1750743X     EISSN: None     Source Type: Journal    
DOI: 10.2217/IMT.09.30     Document Type: Article

References (40)

1. Bendelac A, Savage PB, Teyton L: The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336 (2007).
2. Zhou D, Mattner J, Cantu C III et al.: Lysosomal glycosphingolipid recognition by NKT cells. Science 306(5702), 1786-1789 (2004). (Pubitemid 39601398)
3. Tupin E, Kinjo Y, Kronenberg M: The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5(6), 405-417 (2007).
4. Tyznik AJ, Tupin E, Nagarajan NA et al.: Cutting edge: the mechanism of invariant NKT cell responses to viral danger signals. J. Immunol. 181(7), 4452-4456 (2008).
5. Marschner A, Rothenfusser S, Hornung V et al.: CpG ODN enhance antigen-specific NKT cell activation via plasmacytoid dendritic cells. Eur. J. Immunol. 8(35), 2347-2357 (2005).
6. Fischer K, Scotet E, Niemeyer M et al.: Mycobacterial phosphatidylinositol mannoside is a natural antigen for CD1d-restricted T cells. PNAS 101(29), 10685-10690 (2004). (Pubitemid 38955803)
7. Amprey JL, Im JS, Turco SJ et al.: A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200(7), 895-904 (2004).
8. Kinjo Y, Tupin E, Wu D et al.: Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat. Immunol. 7(9), 978-986 (2006).
9. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB: Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4(12), 1230-1237 (2003).
10. Mattner J, Debord KL, Ismail N et al.: Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434(7032), 525-529 (2005). (Pubitemid 40477062)
11. + NKT cells to initiate contact sensitivity in vivo. J. Immunol. 175(10), 6390-6401 (2005).
12. Tsujimoto H, Ono S, Matsumoto A et al.: A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed Toll-like receptor-9 on liver NKT cells. J. Hepatol. 45(6), 836-843 (2006). (Pubitemid 44646682)
13. Takeda K, Akira S: Toll-like receptors in innate immunity. Int. Immunol. 17(1), 1-14 (2005).
14. Hornung V, Rothenfusser S, Britsch S et al.: Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168(9), 4531-4537 (2002). (Pubitemid 34441357)
15. + T cell populations lacking helper function. Nat. Immunol. 6(2), 163-170 (2005). (Pubitemid 40268197)
16. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J. Exp. Med. 184(2), 747-752 (1996).
17. Sporri R, Reis e Sousa: Newly activated T cells promote maturation of bystander dendritic cells but not IL-12 production. J. Immunol. 171(12), 6406-6413 (2003). (Pubitemid 37532068)
18. Bontkes HJ, Kramer D, Ruizendaal JJ, Kueter EWM, van Tendeloo VFI, Meijer CJLM et al.: Dendritic cells transfected with interleukin-12 and tumor associated antigen mRNA induce high avidity cytotoxic T-cells. Gene Ther. 14(4), 366-375 (2007). (Pubitemid 46231930)
19. Snijders A, Hilkens CM, Van der Pouw Kraan TC, Engel M, Aarden LA, Kapsenberg ML: Regulation of bioactive IL-12 production in lipopolysaccharide- stimulated human monocytes is determined by the expression of the p35 subunit. J. Immunol. 156(3), 1207-1212 (1996). (Pubitemid 26048118)
20. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML et al.: Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J. Invest. Dermatol. 127(2), 331-341 (2007).
21. Magner WJ, Kazim AL, Stewart C et al.: Activation of MHC class I, II, and CD40 gene expression by histone deacetylase inhibitors. J. Immunol. 165(12), 7017-7024 (2000).
22. van der Aar AMG, Sylva-Steenland RMR, Bos JD et al.: Cutting edge: loss of TLR2, TLR4, and TLR5 on langerhans cells abolishes bacterial recognition. J. Immunol. 178(4), 1986-1990 (2007).
23. Montoya CJ, Jie HB, Al Harthi L et al.: Activation of plasmacytoid dendritic cells with TLR9 agonists initiates invariant NKT cell-mediated cross-talk with myeloid dendritic cells. J. Immunol. 177(2), 1028-1039 (2006).
24. Salio M, Speak AO, Shepherd D et al.: Modulation of human natural killer T cell ligands on TLR-mediated antigen-presenting cell activation. Proc. Natl Acad. Sci. USA 104(51), 20490-20495 (2007).
25. Komai-Koma M, Jones L, Ogg GS, Xu D, Liew FY: TLR2 is expressed on activated T cells as a costimulatory receptor. Proc. Natl Acad. Sci. USA 101(9), 3029-3034 (2004).
26. Liew FY, Xu D, Brint EK, O'Neill LA: Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5(6), 446-458 (2005).
27. + T lymphocytes express TLR3 as a functional coreceptor. J. Immunol. 177(12), 8708-8713 (2006).
28. + T cells. J. Immunol. 175(3), 1551-1557 (2005).
29. Paget C, Mallevaey T, Speak AO et al.: Activation of invariant NKT cells by Toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27(4), 597-609 (2007). (Pubitemid 47628833)
30. + T regulatory cells. J. Immunol. 175(12), 8051-8059 (2005). (Pubitemid 41798367)
31. Caramalho I, Lopes-Carvalho T, Ostler D et al.: Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197(4), 403-411 (2003).
32. + regulatory T cells. PNAS 103(18), 7048-7053 (2006).
33. Sutmuller RP, den Brok MH, Kramer M et al.: Toll-like receptor 2 controls expansion and function of regulatory T cells. J. Clin. Invest. 116(2), 485-494 (2006).
34. + regulatory T cell function. Science 309(5739), 1380-1384 (2005). (Pubitemid 41209366)
35. + Tregs and NKT cells: Regulators regulating regulators. Trends Immunol. 27(7), 322-327 (2006).
36. Chen X, Wang X, Keaton JM et al.: Distinct endosomal trafficking requirements for presentation of autoantigens and exogenous lipids by human CD1d molecules. J. Immunol. 178(10), 6181-6190 (2007). (Pubitemid 46717400)
37. Raftery MJ, Winau F, Giese T et al.: Viral danger signals control CD1d de novo synthesis and NKT cell activation. Eur. J. Immunol. 38(3), 668-679 (2008).
38. Spada FM, Borriello F, Sugita M, Watts GF, Koezuka Y, Porcelli SA: Low expression level but potent antigen presenting function of CD1d on monocyte lineage cells. Eur. J. Immunol. 30(12), 3468-3477 (2000).
39. Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ et al.: Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 178(5), 2721-2729 (2007). (Pubitemid 46333148)
40. Vincent MS, Leslie DS, Gumperz JE, Xiong X, Grant EP, Brenner MB: CD1-dependent dendritic cell instruction. Nat. Immunol. 3(12), 1163-1168 (2002).